Basic Information
Valbiotis SA is a French R&D company dedicated to developing drugs for the prevention of cardiometabolic diseases. The company’s product, Valedia, is currently in Phase II clinical trials for the treatment of type 2 diabetes.
Valbiotis SA
GreatEast,France
15~50 people
January 01, 2014
contact@valbiotis.com
Enterprise Profile
Industrial Sector
Concept
Application Scenarios